(Q37820983)

23 August 2017

1 reference

title

Qutenza®: a capsaicin 8% patch for the management of postherpetic neuralgia (English)

1 reference

23 August 2017

Mark Wallace

1

1 reference

23 August 2017

Marco Pappagallo

series ordinal

2

1 reference

23 August 2017

publication date

1 January 2011

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

23 August 2017

published in

1 reference

23 August 2017

volume

11

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

15-27

1 reference

Neuropathic pain: redefinition and a grading system for clinical and research purposes

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

Prevalence of chronic pain with neuropathic characteristics in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

The relationship of pain, allodynia and thermal sensation in post-herpetic neuralgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

Recommendations for the pharmacological management of neuropathic pain: an overview and literature update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

Pharmacotherapy for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

Rational multidrug therapy in the treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

Further evidence for the role of the alpha(2)delta subunit of voltage dependent calcium channels in models of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

Amitriptyline versus placebo in postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

Amitriptyline, but not lorazepam, relieves postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

Desipramine relieves postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

The effectiveness of topically applied capsaicin. A meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

Final Report on the Safety Assessment of Capsicum Annuum Extract, Capsicum Annuum Fruit Extract, Capsicum Annuum Resin, Capsicum Annuum Fruit Powder, Capsicum Frutescens Fruit, Capsicum Frutescens Fruit Extract, Capsicum Frutescens Resin, and Capsaic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

Capsaicin in hot chili pepper: carcinogen, co-carcinogen or anticarcinogen?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

The capsaicin receptor: a heat-activated ion channel in the pain pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

Pharmacokinetic analysis of capsaicin after topical administration of a high-concentration capsaicin patch to patients with peripheral neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

Reduced heat sensitivity and epidermal nerve fiber immunostaining following single applications of a high-concentration capsaicin patch

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

A randomized, controlled, open-label study of the long-term effects of NGX-4010, a high-concentration capsaicin patch, on epidermal nerve fiber density and sensory function in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled study with an open-label extension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

A multicenter, randomized, double-blind, controlled dose finding study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

Effect of EMLA pre-treatment on capsaicin-induced burning and hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

A human oral capsaicin pain model to assess topical anesthetic-analgesic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

Development and validation of a low-literacy opioid contract

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

Concentration-effect relations for intravenous lidocaine infusions in human volunteers: effects on acute sensory thresholds and capsaicin-evoked hyperpathia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

A randomized study of the effect of oral lamotrigine and hydromorphone on pain and hyperalgesia following heat/capsaicin sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

The effect of systemic lidocaine on pain and secondary hyperalgesia associated with the heat/capsaicin sensitization model in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

Lack of effect of two oral sodium channel antagonists, lamotrigine and 4030W92, on intradermal capsaicin-induced hyperalgesia model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

Concentration-effect relationships for intravenous alfentanil and ketamine infusions in human volunteers: effects on acute thresholds and capsaicin-evoked hyperpathia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

Effect of remifentanil on pain and secondary hyperalgesia associated with the heat--capsaicin sensitization model in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

The consequences of long-term topical capsaicin application in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.182

21 January 2018

Identifiers

DOI

10.1586/ERN.10.182

1 reference

23 August 2017

1 reference